Nicardipine Hydrochloride In Sodium Chloride Injection, Solution
Product Images NDC 44567-850
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Nicardipine Hydrochloride In Sodium Chloride (NDC 44567-850). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Wg Critical Care, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Nicardipine HCl In 0.86% Sodium Chloride Injection 20 mg In 200 mL Bag Label Image (Image 02)
This text is a product label for Nicardipine Chloride Injection used for intravenous infusion. The solution is sterile, nonpyrogenic, and for single-dose use only. Each mL contains 0.1 mg Nicardipine hydrochloride, 8.6 mg sodium chloride, citric acid, sorbitol, and may have sodium hydroxide for pH adjustment. It gives cautions about checking for leaks, discarding if found, ensuring solution clarity, and not adding other medications. The usual dosage information is available in the package insert. It should be stored at 20-25°C, protected from freezing and excessive heat, and shielded from light. The product is manufactured in Switzerland by WG Critical Care, LLC.*
Nicardipine HCl In 0.83% Sodium Chloride Injection 40 mg In 200 mL Bag Label Image (Image 03)
The provided text appears to be the label information for a medication called NICARdipine, presented as a single-dose container solution for injection. Each milliliter (mL) of the solution contains 0.2 mg of nicardipine hydrochloride, 8.3 mg of sodium chloride, along with citric acid, sorbitol, and possibly sodium hydroxide for pH adjustment. It is instructed to check for minute leaks by squeezing the bag and discard if leaks are found. The solution should be clear before use, and no additional medications should be added. The medication should not be used in series connections. It is recommended to refer to the package insert for the usual dosage. Storage guidelines include keeping it between 20°C to 25°C, protecting from freezing, excessive heat, and light. The product is manufactured in Switzerland.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.